General Information
Drug ID
DR01198
Drug Name
Gentamicin
Synonyms
(1R,2S,3S,4R,6S)-4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyloxy]-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-beta-L-lyxo-heptopyranoside; (1R,2S,3S,4R,6S)-4,6-diamino-3-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-2-hydroxycyclohexyl (6x)-2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-alpha-D-erythro-heptopyranoside; (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol; 2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol; 4,6-diamino-3-{[3-deoxy-4-c-methyl-3-(methylamino)pentopyranosyl]oxy}-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)heptopyranoside; Alcomicin; Apogen; Bristagen; Cidomycin; G-Mycin; G-Myticin; GENTAMYCIN; Garamycin; Garamycin (TN); Garamycin Otic Solution; Garasol; Genoptic Liquifilm; Genoptic S.O.P.; Gentacidin; Gentacycol; Gentafair; Gentak; Gentamar; Gentamcin Sulfate; Gentamicin (BAN); Gentamicin (TN); Gentamicin C1; Gentamicin sulphate sterile; Gentamicina; Gentamicina [INN-Spanish]; Gentamicine; Gentamicine [INN-French]; Gentamicins; Gentamicinum; Gentamicinum [INN-Latin];Gentamycin-creme; Gentamycin-creme [German]; Gentamycinum; Gentavet; Gentocin; Jenamicin; O-2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-alpha-D-ribo-heptopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy-D-streptamine; Ocu-Mycin; Refobacin; Refobacin TM; Spectro-Genta; U-Gencin; Uromycine
Drug Type
Small molecular drug
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C21H43N5O7
Canonical SMILES
CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
InChI
InChI=1S/C21H43N5O7/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20/h9-20,25-29H,5-8,22-24H2,1-4H3
InChIKey
CEAZRRDELHUEMR-UHFFFAOYSA-N
CAS Number
CAS 1403-66-3
Pharmaceutical Properties Molecular Weight 477.6 Topological Polar Surface Area 200
Heavy Atom Count 33 Rotatable Bond Count 7
Hydrogen Bond Donor Count 8 Hydrogen Bond Acceptor Count 12
XLogP
-4.1
PubChem CID
3467
PubChem SID
103135455 , 104303599 , 117535962 , 124766025 , 126407615 , 126625531 , 126661266 , 126691181 , 127340104 , 127340105 , 127340106 , 134337440 , 134980500 , 135650301 , 137239444 , 142147875 , 152100630 , 160964140 , 196105377 , 223658860 , 226847630 , 242084438 , 246167234 , 250134950 , 29222600 , 46506523 , 4652583 , 49972189 , 53787495 , 57321817 , 74460187 , 8152203 , 92712501 , 96024706
ChEBI ID
ChEBI:17833
TTD Drug ID
D0L9UU

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.